5VM
5AM Venture Management Portfolio holdings
AUM $260M
1-Year Return
3.76%
This Quarter Return
-28.61%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$264M
AUM Growth
-$155M
(-37%)
Cap. Flow
-$8.53M
Cap. Flow
% of AUM
-3.23%
Top 10 Holdings %
Top 10 Hldgs %
63.89%
Holding
32
New
1
Increased
–
Reduced
2
Closed
1
Top Buys
| 1 |
Surrozen
SRZN
|
+$3.61M |
Top Sells
| 1 |
Enliven Therapeutics
ELVN
|
+$6.05M |
| 2 |
Akero Therapeutics
AKRO
|
+$4.59M |
| 3 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
+$1.51M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Adverum Biotechnologies
ADVM
$64.4M
| $2.37M | 0.9% |
541,666
| – | – |
|
|
SLN
27
Silence Therapeutics
SLN
$223M
| $1.34M | 0.51% |
476,200
| – | – |
|
28
Alector
ALEC
$300M
| $1.22M | 0.46% |
995,841
| – | – |
|
29
Cidara Therapeutics
CDTX
$1.7B
| $1.22M | 0.46% |
56,725
| – | – |
|
30
Zentalis Pharmaceuticals
ZNTL
$105M
| $779K | 0.29% |
490,000
| – | – |
|
31
Mersana Therapeutics
MRSN
$35.8M
| $449K | 0.17% |
52,200
| – | – |
|
|
32
Akero Therapeutics
AKRO
$3.43B
| – | – |
-165,000
| Closed | -$4.59M |
|